Ambulation With Labor Epidural in Obese Women

Obesity Clinical Trial

Official title: Neuraxial Analgesia With and Without Ambulation in Laboring Nulliparous Obese Women

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine if ambulation with a labor epidural in place is associated with decreased rate of cesarean delivery in obese patients.

Clinical Trial Description

Obese women are known to have increased risk of cesarean delivery and prolonged labors. Low concentration epidural analgesia can achieve pain relief and allow for ambulation. Prior investigations have not shown a benefit in cesarean delivery between those who ambulate with an epidural and those who do not. These studies were conducted in women with normal weights. It is unknown if ambulation with a labor epidural is beneficial in decreasing cesarean delivery among obese women.

Obese women at term with a singleton pregnancy will be enrolled in this pilot study. Patients will receive their epidural analgesia when they desire per standard protocol at our institution. Following epidural placement, a Modified Bromage Score and straight leg test will be performed. If the patient passes the straight leg test and has a modified Bromage score > 6, they will be allowed to ambulate. They will be encouraged to ambulate for 20 minutes per hour with another adult alongside them. Obstetric care will be standard of care.

On postpartum day one, the patient will be administered a Labor Agentry Scale. Chart review will then be conducted to review maternal and neonatal outcomes. ;

Related Conditions & MeSH terms

• Congenital Abnormalities
• Labor Onset and Length Abnormalities
• Obesity

• NCT number: NCT04504682
• Study type: Interventional
• Source: University of Chicago
• Status: Terminated
• Phase: N/A
• Start date: August 25, 2020
• Completion date: May 31, 2022